152 related articles for article (PubMed ID: 21868071)
1. Alterations of profibrinolytic receptor annexin A2 in pre-eclampsia: a possible role in placental thrombin formation.
Xin H; Zhang Y; Wang H; Sun S
Thromb Res; 2012 May; 129(5):563-7. PubMed ID: 21868071
[TBL] [Abstract][Full Text] [Related]
2. Increased annexin A2 expression in the placenta of women with acute worsening of preeclampsia.
Sano M; Matsumoto M; Terada H; Wang H; Kurihara Y; Wada N; Yamamoto H; Kira Y; Tachibana D; Koyama M
Osaka City Med J; 2014 Dec; 60(2):87-93. PubMed ID: 25803884
[TBL] [Abstract][Full Text] [Related]
3. [Expression changes and clinical significance of annexin V in maternal blood and placenta in patients with preeclampsia].
Xin H; Wang HL
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):88-93. PubMed ID: 21426764
[TBL] [Abstract][Full Text] [Related]
4. Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study.
Abd El-Latif M; Azzam H; Othman M; Warda O; El-Sharawy S; Ghoneim H
Pregnancy Hypertens; 2017 Apr; 8():65-69. PubMed ID: 28501283
[TBL] [Abstract][Full Text] [Related]
5. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia.
Pryor-Koishi K; Nishizawa H; Kato T; Kogo H; Murakami T; Tsuchida K; Kurahashi H; Udagawa Y
BJOG; 2007 Sep; 114(9):1128-37. PubMed ID: 17617189
[TBL] [Abstract][Full Text] [Related]
6. [Expression of fms-like tyrosine kinase receptor 1 in placenta of pre-eclampsia].
Hou XH; Li DH; Li Y; Zhao HX; Zhang CL; Huang L; Yao YQ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):736-9. PubMed ID: 17327029
[TBL] [Abstract][Full Text] [Related]
7. Increased cystatin C expression in the pre-eclamptic placenta.
Kristensen K; Larsson I; Hansson SR
Mol Hum Reprod; 2007 Mar; 13(3):189-95. PubMed ID: 17227816
[TBL] [Abstract][Full Text] [Related]
8. Reduced ANXA5 mRNA and protein expression in pregnancies complicated by preeclampsia.
Gourvas V; Soulitzis N; Konstantinidou A; Dalpa E; Koukoura O; Koutroulakis D; Spandidos DA; Sifakis S
Thromb Res; 2014 Mar; 133(3):495-500. PubMed ID: 24393658
[TBL] [Abstract][Full Text] [Related]
9. [Expression of relaxin receptor in placental tissues of normal pregnancy and pre-eclampsia].
Wang YQ; Li J; Yang Z
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):269-71. PubMed ID: 18843967
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of hypoxia inducible factor-prolyl hydroxylase 1 and factor inhibiting hypoxia inducible factor-1 expression in placentas of women with severe pre-eclampsia].
Luan NN; Qiao C; Jin F; Liu WH; Shang T
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):913-7. PubMed ID: 19134330
[TBL] [Abstract][Full Text] [Related]
11. Alterations of maternal serum and placental follistatin-like 3 and myostatin in pre-eclampsia.
Guo J; Tian T; Lu D; Xia G; Wang H; Dong M
J Obstet Gynaecol Res; 2012 Jul; 38(7):988-96. PubMed ID: 22568578
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin in human pregnancy and pre-eclampsia.
Gu VY; Wong MH; Stevenson JL; Crawford KE; Brennecke SP; Gude NM
Mol Hum Reprod; 2008 May; 14(5):309-15. PubMed ID: 18417548
[TBL] [Abstract][Full Text] [Related]
13. [Differential expression of adrenomedullin in the placentas of women with normal and preeclamptic pregnancies in late term].
Gao YF; Yu YH; Li ZQ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1828-30. PubMed ID: 17259131
[TBL] [Abstract][Full Text] [Related]
14. Contribution of fetal ANXA5 gene promoter polymorphisms to the onset of pre-eclampsia.
Ota S; Miyamura H; Nishizawa H; Inagaki H; Inagaki A; Inuzuka H; Suzuki M; Miyazaki J; Sekiya T; Udagawa Y; Kurahashi H
Placenta; 2013 Dec; 34(12):1202-10. PubMed ID: 24140079
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients.
Nishizawa H; Pryor-Koishi K; Suzuki M; Kato T; Kogo H; Sekiya T; Kurahashi H; Udagawa Y
Mol Hum Reprod; 2008 Oct; 14(10):595-602. PubMed ID: 18805800
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia.
Inagaki A; Nishizawa H; Ota S; Suzuki M; Inuzuka H; Miyamura H; Sekiya T; Kurahashi H; Udagawa Y
Placenta; 2012 Nov; 33(11):919-26. PubMed ID: 22964307
[TBL] [Abstract][Full Text] [Related]
17. Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia.
Al-Ghafra A; Gude NM; Brennecke SP; King RG
Mol Hum Reprod; 2006 Mar; 12(3):181-6. PubMed ID: 16517613
[TBL] [Abstract][Full Text] [Related]
18. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
Teng Y; Jiang R; Lin Q; Ding C; Ye Z
Thromb Res; 2010 Jul; 126(1):e41-5. PubMed ID: 20226500
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M as a target biological molecule of preeclampsia.
Lee G; Kil G; Kwon J; Kim S; Yoo J; Shin J
J Obstet Gynaecol Res; 2009 Oct; 35(5):869-75. PubMed ID: 20149034
[TBL] [Abstract][Full Text] [Related]
20. Decreased annexin A5 mRNA placental expression in pregnancies complicated by fetal growth restriction.
Sifakis S; Soufla G; Koukoura O; Soulitzis N; Koutroulakis D; Maiz N; Konstantinidou A; Melissari E; Spandidos DA
Thromb Res; 2010 Apr; 125(4):326-31. PubMed ID: 20034656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
